Atlas Trials

Adagene Inc

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Adagene Inc

RecordFirmDate
Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors (NCT05614258)Adagene Inc2023-02-13
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05405595)Adagene Inc2022-06-15
ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05277402)Adagene Inc2022-02-09
ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors (NCT04645069)Adagene Inc2021-03-15
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients (NCT04501276)Adagene Inc2020-09-23
Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors (NCT04111445)Adagene Inc2019-08-29
Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma (NCT03707093)Adagene Inc2018-09-17

Track Adagene Inc automatically

Every clearance here is in the API, with alerts when new ones post.